Telomere Length and Type 2 Diabetes: What Researchers Observed

Telomere Length and Type 2 Diabetes: What Researchers Observed

Another interesting November research article recently published deals with the shortening of telomeres as the missing link between aging and type 2 Diabetes (AGING, 2010, Vol 2 no 10:650). As stated before telomere shortening, either because there is no telomerase activity or by some other mechanism, have been documented to be associated to diseases of aging. In the present study a group of scientist led by Michael Ristow used mice to establish a link between Diabetes and telomere shortening. In their study, the group utilized mice that had their telomerase enzyme modified in such a way that it was inactivated. This resulted in telomere shortening and reduced replicative capacity of beta-cells (the pancreatic cells that produce insulin). The lack of insulin secretion and the increase of glucose intolerance can therefore be viewed as an aging-associated disorder and method of increasing telomerase activity could result in improvements in this disease.

Interested in TA-65?

RevGenetics carries authentic TA-65, independently verified.

Shop Now →
Anthony Loera

About the Author

Anthony Loera

Founder & President, RevGenetics

Anthony Loera founded RevGenetics in 2007 and leads research and development, reviewing published research on emerging longevity compounds and setting the company's manufacturing, sourcing and formulation-stability standards. He is not a research scientist; mechanistic and scientific review is handled by Chief Science Officer Dr. Hector Valenzuela, Ph.D.

Full bio →